Scholars@Duke publication: Bleeding risk with ischemic stroke therapy

Bleeding risk with ischemic stroke therapy - Reply

Publication , Journal Article

Xian, Y; Liang, L; Peterson, ED

Published in: JAMA

October 3, 2012

Published version (DOI) Open Access Copy (Duke)

Duke Scholars

Author Ying Xian Neurology, Neurocritical Care

Published In

JAMA

DOI

10.1001/2012.jama.11667

EISSN

1538-3598

ISSN

0098-7484

Publication Date

October 3, 2012

Volume

308

Issue

Start / End Page

1319 / 1320

Related Subject Headings

General & Internal Medicine
42 Health sciences
32 Biomedical and clinical sciences
11 Medical and Health Sciences

Citation

APA

Chicago

ICMJE

MLA

NLM

Xian, Y., Liang, L., & Peterson, E. D. (2012). Bleeding risk with ischemic stroke therapy - Reply. JAMA, 308(13), 1319–1320. https://doi.org/10.1001/2012.jama.11667

Xian, Y., L. Liang, and E. D. Peterson. “Bleeding risk with ischemic stroke therapy - Reply.” JAMA 308, no. 13 (October 3, 2012): 1319–20. https://doi.org/10.1001/2012.jama.11667.

Xian Y, Liang L, Peterson ED. Bleeding risk with ischemic stroke therapy - Reply. JAMA. 2012 Oct 3;308(13):1319–20.

Xian, Y., et al. “Bleeding risk with ischemic stroke therapy - Reply.” JAMA, vol. 308, no. 13, Oct. 2012, pp. 1319–20. Scopus, doi:10.1001/2012.jama.11667.

Xian Y, Liang L, Peterson ED. Bleeding risk with ischemic stroke therapy - Reply. JAMA. 2012 Oct 3;308(13):1319–1320.

Published In

JAMA

DOI

10.1001/2012.jama.11667

EISSN

1538-3598

ISSN

0098-7484

Publication Date

October 3, 2012

Volume

308

Issue

Start / End Page

1319 / 1320

Related Subject Headings

General & Internal Medicine
42 Health sciences
32 Biomedical and clinical sciences
11 Medical and Health Sciences